MARKET

SPRO

SPRO

Spero Therapeuti
NASDAQ
1.010
-0.060
-5.61%
After Hours: 1.010 0 0.00% 16:30 11/10 EST
OPEN
1.070
PREV CLOSE
1.070
HIGH
1.070
LOW
1.010
VOLUME
183.74K
TURNOVER
--
52 WEEK HIGH
3.080
52 WEEK LOW
0.9610
MARKET CAP
58.82M
P/E (TTM)
26.51
1D
5D
1M
3M
1Y
5Y
1D
*Spero Therapeutics Appoints William Ho to Its Bd of Directors
Dow Jones · 9h ago
Press Release: Spero Therapeutics Appoints William Ho, M.D., Ph.D., to its Board of Directors
Dow Jones · 9h ago
Weekly Report: what happened at SPRO last week (1102-1106)?
Weekly Report · 1d ago
Alphabet maintains massive SpaceX bet, initiates $548M Qualcomm stake
Seeking Alpha · 1d ago
Weekly Report: what happened at SPRO last week (1026-1030)?
Weekly Report · 11/02 09:42
This Rubrik Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday
Benzinga · 10/29 18:32
Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE), Korro Bio (KRRO) and Spero Therapeutics (SPRO)
TipRanks · 10/29 08:50
Cantor Fitzgerald Initiates Coverage of Spero Therapeutics at Overweight
NASDAQ · 10/29 02:26
More
About SPRO
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying and developing novel treatments for rare diseases and diseases caused by multi-drug resistant (MDR) bacterial infections with unmet need. Its product candidate SPR720 is an investigational, chemically stable phosphate ester prodrug that is converted in vivo to SPR719 for the treatment of nontuberculous mycobacterial (NTM) pulmonary disease. Its clinical stage product candidate, tebipenem HBr is an investigational oral carbapenem antibiotic being developed for the treatment of complicated urinary tract infections (cUTIs) including acute pyelonephritis (AP) to help patients potentially reduce duration of in-patient therapy.

Webull offers Spero Therapeutics Inc stock information, including NASDAQ: SPRO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SPRO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SPRO stock methods without spending real money on the virtual paper trading platform.